An oral anti cancer drug. Works by inhibiting cellular signals by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib is approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) Reference standards of Sunitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => (Z)-N-Ethyl-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]- 2,4-dimethyl-1H-pyrrole-3-carboxamide [catalogue_number] => PA 19 75520 [category_ids] => 89,82,80,79,78,71,70 [chemical_name] => [weight] => 327.35 [form] => C18H18FN3O2 [cas] => NA [pslug] => z-n-ethyl-5-5-fluoro-1-2-dihydro-2-oxo-3h-indol-3-ylidene-methyl-2-4-dimethyl-1h-pyrrole-3-carboxamide-pa1975520 [latest_product] => 0 [linkproducts] => 0 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 42917 [offers_product_code] => PA 19 75520 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 19 75520
CAS :
Molecular Formula : C18H18FN3O2
Molecular Weight : 327.35
stdClass Object ( [pname] => Sunitinib Amide Impurity [catalogue_number] => PA 19 75550 [category_ids] => ,78,70,82,89,79,80, [chemical_name] => [weight] => 299.3 [form] => C16H14FN3O2 [cas] => 1186651-51-3 [pslug] => 1186651-51-3-sunitinib-amide-impurity-pa1975550 [latest_product] => 0 [linkproducts] => 0 [offers_id] => 8 [offers_name] => Ready Stock [offers_status] => 1 [offers_start_date] => 2024-12-16 [offers_end_date] => 2024-12-31 [pageview] => 2 [offers_slug] => ready-stock [offers_product_id] => 42921 [offers_product_code] => PA 19 75550 [offers_master_id] => 8 [offer_percentage] => 20 % OFF [offers_product_main_cat] => Pharmaceutical Reference Standards )
Catalogue No.:PA 19 75550
Molecular Formula : C16H14FN3O2
Molecular Weight : 299.3
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
